EMEA (Europe, Middle East and Africa) Biopharmaceuticals Market Report 2018

SKU ID : QYR- 11870599

Publishing Date : 25-Jun-2018

No. of pages : 101

PRICE
4000
8000


  • In this report, the EMEA Biopharmaceuticals market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

    Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Biopharmaceuticals for these regions, from 2013 to 2025 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

    EMEA Biopharmaceuticals market competition by top manufacturers/players, with Biopharmaceuticals sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Roche
    Amgen
    AbbVie
    Sanofi-Aventis
    Johnson & Johnson
    Pfizer
    Novo Nordisk
    Eli Lilly
    Novartis
    Merck

    On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Monoclonal Antibodies
    Interferon
    Colony-Stimulating Factor
    Erythropoietin
    Insulin
    Vaccines
    Growth Hormones
    Others

    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Tumor
    Diabetes
    Cardiovascular
    Hemophilia
    Others